SEC Form 4 · accession 0001127602-16-037241
HAEMONETICS CORP · HAE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher J Lindop
Officer — CFO & EVP Business Development
Period of report
Jan 13, 2016
Accepted (ET)
Jan 19, 2016 · 5:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000313143
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jan 13, 2016 | A | 11,393 | $0.01 | A | 56,743 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Restricted Stock Unit grant which vests on the first anniversary of the grant date. Grant was made under 2005 Long Term Incentive Compensation Plan.
- F2Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.